Prostate carcinoma.
Over the last several years, the development of prostate-specific antigen (PSA) testing and technical refinements of anatomic radical prostatectomy have revolutionized the care of patients with prostate cancer. Serum PSA testing often allows early diagnosis of organ-confined prostate cancer. Anatomical radical prostatectomy has a high probability of completely eradicating these tumors, with minimal long-term morbidity. Use of PSA testing after therapy confirms the long-term ability of surgery to eradicate early-stage prostate cancer.
Andriole
G L
GL
Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
Catalona
W J
WJ
D002277:Carcinoma / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D010808:Physical Examination; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery; D012007:Rectum; D014463:Ultrasonography
D017430:Prostate-Specific Antigen